Validation of the eleven-point pain scale in the measurement of migraine headache pain

Cephalalgia

Volumn 27, Issue 4, 2007, Pages 336-342

  Kwong, W J ^a   Pathak, D S ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Migraine; Pain; Psychometrics; Scales; Validity

Indexed keywords

NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; TRIPTAN DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EMOTION; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PAIN; PAIN ASSESSMENT; QUALITY OF LIFE; VALIDITY;

ADULT; COMORBIDITY; FEMALE; HEADACHE; HUMANS; MALE; MIGRAINE DISORDERS; NORTH CAROLINA; OHIO; PAIN MEASUREMENT; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 33947196985     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2007.01283.x     Document Type: Article

References (20)

1. Santanello NC, Davies G, Allen C, Kramer M, Lipton R. Determinants of migraine-specific quality of life. Cephalalgia 2002; 22:680-5.
2. Baillie L. A review of pain assessment tools. Nursing Standard 1993; 24:25-9.
3. Ho K, Spence J, Murphy MF. Review of pain-measurement tools. Ann Emergency Med 1996; 27:427-32.
4. Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain 1992; 50:133-49.
5. Von Korff M, Stewart WF, Lipton RB. Assessing headache severity. New directions. Neurology 1994; 44 (Suppl. 4):S40-S46.
6. Lipton RB, Goadsby PJ, Sawyer JPC, Blakeborough P, Stewart WF. Migraine: diagnosis and assessment of disability. Rev Contemp Pharmacother 2000; 11:63-73.
7. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 (Suppl. 7):1-96.
8. Campbell DR, Fiske DW. Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull 1959; 56:81-105.
9. Guyatt GH, Deyo RA, Charlson M, Levine MN, Mitchell A. Responsiveness and validity in health status measurement: a clarification. J Clin Epidemiol 1989; 42:403-8.
10. Osterhaus JT, Townsend RJ, Gandek B, Ware JE Jr. Measuring the functional status and well-being of patients with migraine headache. Headache 1994; 34:337-43.
11. Schwartz BS, Stewart WF, Lipton RB. Lost workdays and decreased work effectiveness associated with headache in the workplace. J Occup Environ Med 1997; 39:320-7.
12. Smith R. Impact of migraine on the family. Headache 1998; 38:423-6.
13. Clouse JC, Osterahus JT. Healthcare resource use and costs associated with migraine in a managed healthcare setting. Ann Pharmacother 1994; 28:659-64.
14. Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med 1999; 159:813-8.
15. Ohnhaus EE, Adler R. Methodological problems in the measurement of pain: a comparison between the verbal rating scale and the visual analogue scale. Pain 1975; 1:379-84.
16. Littman GS, Walker BR, Schneider BE. Reassessment of verbal and visual analog ratings in analgesic studies. Clin Pharmacol Ther 1985; 38:16-23.
17. Jensen MP, Chen C, Brugger AM. Postsurgical pain outcome assessment. Pain 2002; 99:101-9.
18. Lipton RB, Stewart WF. Acute migraine therapy: do doctors understand what patients with migraine want from therapy. Headache 1999; 39:S20-S26.
19. Davies GM, Santanello N, Lipton R. Determinants of patient satisfaction with migraine therapy. Cephalalgia 2000; 20:554-60.
20. Martin BC, Pathak DS, Sharfman MI, Adelman JU, Taylor F, Kwong WJ et al. Validity and reliability of the Migraine-Specific Quality of Life Questionnaire (MSQ Version 2.1). Headache 2000; 40:204-15.